3/27
02:29 pm
mrk
Jim Cramer on Merck & Co.: “If We're Really Going Into an Oil Shock-Induced Slowdown, I Think This One's Likely an Outperformer”” [Yahoo! Finance]
Low
Report
Jim Cramer on Merck & Co.: “If We're Really Going Into an Oil Shock-Induced Slowdown, I Think This One's Likely an Outperformer”” [Yahoo! Finance]
3/27
09:38 am
mrk
Merck Targets Post Keytruda Future With US$6.7b Terns Acquisition [Yahoo! Finance]
Low
Report
Merck Targets Post Keytruda Future With US$6.7b Terns Acquisition [Yahoo! Finance]
3/27
08:06 am
mrk
Agilent receives FDA approval for PD-L1 1HC 22C3 pharmDx [Yahoo! Finance]
Low
Report
Agilent receives FDA approval for PD-L1 1HC 22C3 pharmDx [Yahoo! Finance]
3/27
06:17 am
mrk
Merck's deal for Terns sparks debate over a possible biotech bidding war [Yahoo! Finance]
Low
Report
Merck's deal for Terns sparks debate over a possible biotech bidding war [Yahoo! Finance]
3/26
09:02 pm
mrk
RBC Reiterates Merck (MRK) Outperform, Notes Investor Concerns Over “Modest Premium” [Yahoo! Finance]
Low
Report
RBC Reiterates Merck (MRK) Outperform, Notes Investor Concerns Over “Modest Premium” [Yahoo! Finance]
3/25
08:25 am
mrk
Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline [MSNBC.com]
Low
Report
Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline [MSNBC.com]
3/25
06:45 am
mrk
Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML)
Low
Report
Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML)
3/24
07:33 am
mrk
New Public Listings for Canadians Living with Pulmonary Arterial Hypertension [Globe and Mail, The (Toronto, Canada)]
Low
Report
New Public Listings for Canadians Living with Pulmonary Arterial Hypertension [Globe and Mail, The (Toronto, Canada)]
3/24
07:14 am
mrk
Organon: A High Cash Yield Hidden Behind Patent Fatigue [Yahoo! Finance]
Low
Report
Organon: A High Cash Yield Hidden Behind Patent Fatigue [Yahoo! Finance]
3/20
04:17 pm
mrk
'My Dad Lost Everything': Jim Cramer 'Willing To Expose' His Father For Picking The Wrong Stock — And Missing Multimillionaire Opportunity [Yahoo! Finance]
Low
Report
'My Dad Lost Everything': Jim Cramer 'Willing To Expose' His Father For Picking The Wrong Stock — And Missing Multimillionaire Opportunity [Yahoo! Finance]
3/20
03:47 pm
mrk
Merck & Co., Inc. (MRK) had its price target raised by Citigroup Inc. from $120.00 to $125.00. They now have a "neutral" rating on the stock.
Low
Report
Merck & Co., Inc. (MRK) had its price target raised by Citigroup Inc. from $120.00 to $125.00. They now have a "neutral" rating on the stock.
3/19
03:56 pm
mrk
Pfizer vs Moderna: Which Pharma Stock Has More Upside? [Yahoo! Finance]
Low
Report
Pfizer vs Moderna: Which Pharma Stock Has More Upside? [Yahoo! Finance]
3/19
10:55 am
mrk
Moon Rabbit Appoints Loren Levinson EVP, Executive Strategy Director
Low
Report
Moon Rabbit Appoints Loren Levinson EVP, Executive Strategy Director
3/19
06:20 am
mrk
Merck & Co., Inc. (MRK) was upgraded by Zacks Research from "strong sell" to "hold".
Low
Report
Merck & Co., Inc. (MRK) was upgraded by Zacks Research from "strong sell" to "hold".
3/18
04:30 pm
mrk
FDA Approves BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) from Merck Animal Health to Treat and Control Asian Longhorned Tick and Gulf Coast Tick for 12 Months in Dogs
Low
Report
FDA Approves BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) from Merck Animal Health to Treat and Control Asian Longhorned Tick and Gulf Coast Tick for 12 Months in Dogs
3/17
06:21 pm
mrk
FTC monitoring how drug companies react to patent cliff, official says 1 / 4 Dan Guarnera answers questions posed by Reuters Antitrust Correspondent Jody Godoy at Reuters Pharma USA in Philadelphia Dan Guarnera, who leads antitrust enforcement at the U.S.
Low
Report
FTC monitoring how drug companies react to patent cliff, official says 1 / 4 Dan Guarnera answers questions posed by Reuters Antitrust Correspondent Jody Godoy at Reuters Pharma USA in Philadelphia Dan Guarnera, who leads antitrust enforcement at the U.S.
3/17
06:13 pm
mrk
FTC monitoring how drug companies react to patent cliff, official says [Yahoo! Finance]
Low
Report
FTC monitoring how drug companies react to patent cliff, official says [Yahoo! Finance]
3/17
09:38 am
mrk
Imfinzi EU Approval Expands AstraZeneca Gastric Cancer Reach For Investors [Yahoo! Finance]
Low
Report
Imfinzi EU Approval Expands AstraZeneca Gastric Cancer Reach For Investors [Yahoo! Finance]
3/17
07:36 am
mrk
Yahoo Finance [Yahoo! Finance]
Low
Report
Yahoo Finance [Yahoo! Finance]
3/17
06:50 am
mrk
Merck to Present New Data Reinforcing Long-Term Efficacy of GARDASIL®9 and GARDASIL® at the EUROGIN International Multidisciplinary HPV Congress 2026
Low
Report
Merck to Present New Data Reinforcing Long-Term Efficacy of GARDASIL®9 and GARDASIL® at the EUROGIN International Multidisciplinary HPV Congress 2026
3/17
01:43 am
mrk
Wells Fargo Raises Merck (MRK) Target on Sac-TMT Potential [Yahoo! Finance]
Low
Report
Wells Fargo Raises Merck (MRK) Target on Sac-TMT Potential [Yahoo! Finance]
3/16
08:12 am
mrk
Merck Highlights New Data from Cardio-Pulmonary Pipeline at ACC.26 Showcasing Commitment to Advance Innovative Research [Yahoo! Finance]
Low
Report
Merck Highlights New Data from Cardio-Pulmonary Pipeline at ACC.26 Showcasing Commitment to Advance Innovative Research [Yahoo! Finance]
3/16
08:00 am
mrk
Merck Highlights New Data from Cardio-Pulmonary Pipeline at ACC.26 Showcasing Commitment to Advance Innovative Research
Low
Report
Merck Highlights New Data from Cardio-Pulmonary Pipeline at ACC.26 Showcasing Commitment to Advance Innovative Research
3/15
09:08 pm
mrk
Is Merck & Co., Inc. (MRK) A Good Stock To Buy Now? [Yahoo! Finance]
Low
Report
Is Merck & Co., Inc. (MRK) A Good Stock To Buy Now? [Yahoo! Finance]
3/15
06:12 pm
mrk
This is What Merck & Co. (MRK) is Doing to Mitigate Against KEYTRUDA Exclusivity Loss [Yahoo! Finance]
Low
Report
This is What Merck & Co. (MRK) is Doing to Mitigate Against KEYTRUDA Exclusivity Loss [Yahoo! Finance]